相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions
Urvi H. Gala et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Overview of the Manufacturing Methods of Solid Dispersion Technology for Improving the Solubility of Poorly Water-Soluble Drugs and Application to Anticancer Drugs
Phuong Tran et al.
PHARMACEUTICS (2019)
Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells
Mariya B. Sokol et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2019)
Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSolA (R): a Review
Daniel J. Ellenberger et al.
AAPS PHARMSCITECH (2018)
HPMCAS as an effective precipitation inhibitor in amorphous solid dispersions of the poorly soluble drug candesartan cilexetil
Juliana Munari Oliveira Pinto et al.
CARBOHYDRATE POLYMERS (2018)
Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update
Scott V. Jermain et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Thermal conductivity of polymers and polymer nanocomposites
Congliang Huang et al.
MATERIALS SCIENCE & ENGINEERING R-REPORTS (2018)
Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes
Phennapha Saokham et al.
MOLECULES (2018)
Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study
Cy A. Stein et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Influence of NaCl Concentration on Food-Waste Biochar Structure and Templating Effects
Ye-Eun Lee et al.
ENERGIES (2018)
Solubility Measurements at 296 and 310 K and Physicochemical Characterization of Abiraterone and Abiraterone Acetate
Tamas Solymosi et al.
JOURNAL OF CHEMICAL AND ENGINEERING DATA (2018)
Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport
Venecia Wilson et al.
JOURNAL OF CONTROLLED RELEASE (2018)
2-Hydroxypropyl--Cyclodextrin Aggregates: Identification and Development of Analytical Techniques
Andre Rodrigues Sa Couto et al.
MATERIALS (2018)
Design and Molecular Modeling of Abiraterone-Functionalized Gold Nanoparticles
Elibieta U. Stolarczyk et al.
NANOMATERIALS (2018)
Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer
Xu Steven Xu et al.
CLINICAL PHARMACOKINETICS (2017)
Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements
Tamas Solymosi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
An approach for chemical stability during melt extrusion of a drug substance with a high melting point
Abbe Haser et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies
Ronald Goldwater et al.
CLINICAL PHARMACOKINETICS (2017)
Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions
Justin S. LaFountaine et al.
AAPS PHARMSCITECH (2016)
Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review
Justin S. LaFountaine et al.
AAPS PHARMSCITECH (2016)
Pharmacokinetics of cyclodextrins and drugs after oral and parenteral administration of drug/cyclodextrin complexes
Thorsteinn Loftsson et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma
Chandraiah Godugu et al.
PHARMACEUTICAL RESEARCH (2016)
Spray drying formulation of amorphous solid dispersions
Abhishek Singh et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Inventory of oral anticancer agents: Pharmaceutical formulation aspects with focus on the solid dispersion technique
E. Sawicki et al.
CANCER TREATMENT REVIEWS (2016)
Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate-Treated Castration-Resistant Prostate Cancer Patients
Xu S. Xu et al.
CLINICAL CANCER RESEARCH (2015)
Enhancement of docetaxel solubility using binary and ternary solid dispersion systems
Sue May Lim et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques
Fan Meng et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: In vitro, rat in situ and human in vivo studies
Jef Stappaerts et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
High speed electrospinning for scaled-up production of amorphous solid dispersion of itraconazole
Zsombor K. Nagy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Food Effects on Abiraterone Pharmacokinetics in Healthy Subjects and Patients With Metastatic Castration-Resistant Prostate Cancer
Kim N. Chi et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Equilibrium State at Supersaturated Drug Concentration Achieved by Hydroxypropyl Methylcellulose Acetate Succinate: Molecular Characterization Using 1H NMR Technique
Keisuke Ueda et al.
MOLECULAR PHARMACEUTICS (2015)
Stability assessment of hypromellose acetate succinate (HPMCAS) NF for application in hot melt extrusion (HME)
Ashish L. Sarode et al.
CARBOHYDRATE POLYMERS (2014)
The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvement
Keisuke Ueda et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Amorphous Stabilization and Dissolution Enhancement of Amorphous Ternary Solid Dispersions: Combination of Polymers Showing Drug-Polymer Interaction for Synergistic Effects
Dev Prasad et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Drug precipitation inhibitors in supersaturable formulations
Sen Xu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Analysis of abiraterone stress degradation behavior using liquid chromatography coupled to ultraviolet detection and electrospray ionization mass spectrometry
Alaa Khedr et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process
Navnit Shah et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Abiraterone Inhibits 3β-Hydroxysteroid Dehydrogenase: A Rationale for Increasing Drug Exposure in Castration-Resistant Prostate Cancer
Rui Li et al.
CLINICAL CANCER RESEARCH (2012)
Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing
Meimei Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier
Justin R. Hughey et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Cyclodextrins as functional excipients: Methods to enhance complexation efficiency
Thorsteinn Loftsson et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001
Natasha M. DeVore et al.
NATURE (2012)
Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
Yasser Rehman et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2012)
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Joachim Brouwers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu
William Curatolo et al.
PHARMACEUTICAL RESEARCH (2009)
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
Gerhardt Attard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview
Dwayne T. Friesen et al.
MOLECULAR PHARMACEUTICS (2008)
Compounding of nanocomposites by thermokinetic mixing
TG Gopakumar et al.
JOURNAL OF APPLIED POLYMER SCIENCE (2005)
The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs
T Loftsson et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2004)
分享论文
